When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EVOK - Evoke Pharma receives CRL for Gimoti NDA; shares down 38% premarket
Evoke Pharma Inc.
Evoke Pharma (NASDAQ:EVOK) has received a Complete Response Letter (CRL) from the FDA for its 505(b)(2) NDA for Gimoti for the relief of symptoms associated with acute and recurrent diabetic gastroparesis.
More news on: Evoke Pharma, Inc., Healthcare stocks news, Stocks on the move,